IconOVir Bio

📍 San Diego, United States👥 19 employees💰 Last funded Jan 2021
Biotechnology Research🌐 iconovir.com
Website LinkedIn
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in IconOVir Bio?
IconOVir Bio has 1 investors on record on gritt.io.
When did IconOVir Bio last raise funding?
The most recent investment in IconOVir Bio recorded on gritt.io was in January 2021.
What industry is IconOVir Bio in?
IconOVir Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IconOVir Bio based?
IconOVir Bio is headquartered in San Diego, United States.